Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Melinda S Epstein"'
Autor:
Kenneth B Lewis, Richard J Hughes, Melinda S Epstein, Neil C Josephson, Christine L Kempton, Craig M Kessler, Nigel S Key, Tom E Howard, Rebecca Kruse-Jarres, Jeanne M Lusher, Christopher E Walsh, Raymond G Watts, Ruth A Ettinger, Kathleen P Pratt, PATH (Personalized Alternative Therapies for Haemophilia) Study Investigators
Publikováno v:
PLoS ONE, Vol 8, Iss 5, p e61120 (2013)
Evidence of antibody isotype/subtype switching may provide prognostic value regarding the state of immune responses to therapeutic proteins, e.g. anti-factor VIII (FVIII) antibodies that develop in many hemophilia A patients, clinically termed "inhib
Externí odkaz:
https://doaj.org/article/ed2b94404c024e57811b2da41995a2a6
Publikováno v:
Annals of surgical oncology. 29(6)
Autor:
Melvin J. Silverstein, Melinda S. Epstein, Peter Chen, Kevin Lin, Sadia Khan, Lincoln Snyder, Colleen Coleman, Lisa Guerra, Farideh Dehkordi-Vakil, Brian Kim
Publikováno v:
Annals of Surgical Oncology
Introduction Intraoperative radiotherapy (IORT) permits accurate delivery of radiation therapy directly to the tumor bed. We report local, regional, and distant recurrence data along with overall and breast cancer-specific survival for 1400 tumors tr
Publikováno v:
Annals of Surgical Oncology. 29:3737-3738
Autor:
Melvin J. Silverstein, Melinda S. Epstein, Peter Chen, Kevin Lin, Sadia Khan, Lincoln Snyder, Colleen Coleman, Lisa Guerra, Farideh Dehkordi-Vakil, Brian Kim
Publikováno v:
Annals of Surgical Oncology. 29:3739-3739
Autor:
Peter Chen, Melvin J. Silverstein, Brian S. Kim, Lisa E. Guerra, Kevin K. Lin, Melinda S. Epstein, Lincoln Snyder, Sadia Khan, Colleen Coleman
Publikováno v:
Cancer Research. 81:PS15-11
Introduction: Two prospective randomized trials, TARGIT-A and ELIOT, have shown intraoperative radiation therapy (IORT) to be a safe alternative with a low-risk of local recurrence compared to whole breast radiation therapy following breast conservin
Ductal carcinoma in situ (DCIS) of the breast is a heterogeneous group of lesions with diverse malignant potential and a range of treatment options. It is the most rapidly growing subgroup in the breast cancer family of disease with more than 60,000
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7a2dcbb29167b9dba5b07ff6dcc19e42
https://doi.org/10.1016/b978-0-323-35955-9.00039-8
https://doi.org/10.1016/b978-0-323-35955-9.00039-8
Autor:
Balkees Abderrahman, Stefan Aebi, Prasanna Alluri, Benjamin O. Anderson, Cletus A. Arciero, Raheela Ashfaq, Thomas Aversano, Jennifer Axilbund, Ebrahim Azizi, Rajesh Banderudrappagari, Andrea V. Barrio, Lawrence W. Bassett, Isabelle Bedrosian, Alyssa Berkowitz, Therese B. Bevers, Kirby I. Bland, Cristiano Boneti, Zeynep Bostanci, Ursa Brown-Glaberman, Adam Brufsky, Gwendolyn Bryant-Smith, Oren Cahlon, Benjamin C. Calhoun, Kristine E. Calhoun, Ryan J. Carr, Helena R. Chang, Steven L. Chen, Alice Chung, Maureen A. Chung, Hiram S. Cody, Edward M. Copeland, Ricardo Costa, Jorge I. de la Torre, Amy C. Degnim, Mary L. Disis, William D. Dupont, Melinda S. Epstein, Francisco J. Esteva, David M. Euhus, Suzanne Evans, Oluwadamilola M. Fayanju, Gary M. Freedman, Patrick Bryan Garvey, Abby Geletzke, Mary L. Gemignani, Armando E. Giuliano, Mehra Golshan, William J. Gradishar, Jill Granger, Caprice C. Greenberg, Lars J. Grimm, Stephen R. Grobmyer, Nora Hansen, Ramdane Harouaka, Eleanor E. Harris, Lynn C. Hartmann, Tina J. Hieken, Susan Higgins, Dennis Holmes, Kelly K. Hunt, E. Shelley Hwang, Reshma Jagsi, Sarika Jain, Bharti Jasra, Jacqueline S. Jeruss, Rafael E. Jimenez, Veronica Jones, V. Craig Jordan, Himanshu Joshi, Virginia Kaklamani, Nina J. Karlin, Meghan S. Karuturi, Rena B. Kass, Kenneth Kern, Seema A. Khan, Jennifer R. Klemp, V. Suzanne Klimberg, Soheila Korourian, Henry M. Kuerer, Asangi R. Kumarapeli, Priya Kumthekar, Maryann Kwa, Michael D. Lagios, Jeffrey Landercasper, Kate I. Lathrop, Gordon K. Lee, Stephanie Lee-Felker, A. Marilyn Leitch, D. Scott Lind, Charles L. Loprinzi, Anthony Lucci, Tahra Kaur Luther, Neil Majithia, Issam Makhoul, Melissa Anne Mallory, Anne T. Mancino, Sanjay Maraboyina, Aju Mathew, Damian McCartan, Susan A. McCloskey, Beryl McCormick, Karishma Mehra, Jane E. Mendez, Priya V. Mhatre, Michael D. Mix, Meena S. Moran, Molly Moravek, Leigh Neumayer, Samilia Obeng-Gyasi, Patience Odele, Maureen O'Donnell, Colleen M. O'Kelly Priddy, Ruth M. O'Regan, Sonal Oza, Holly J. Pederson, Angela Pennisi, Margot S. Peters, Sara B. Peters, Lindsay F. Petersen, Melissa Pilewskie, Raquel Prati, Michael F. Press, Erik Ramos, Amy E. Rivere, Arlan L. Rosenbloom, Kathryn J. Ruddy, Kilian E. Salerno, Melinda E. Sanders, Tara Sanft, Cesar A. Santa-Maria, Jennifer Sasaki, Nirav B. Savalia, Chirag Shah, Samman Shahpar, Yu Shyr, Melvin J. Silverstein, Jean F. Simpson, George W. Sledge, Karen Lisa Smith, Stephen M. Smith, George Somlo, Sasha E. Stanton, Vered Stearns, Matthew A. Steliga, Alison T. Stopeck, Toncred M. Styblo, Susie X. Sun, Melinda L. Telli, Amye J. Tevaarwerk, Parijatham S. Thomas, Nicholas D. Tingquist, Jacqueline Tsai, Stephanie A. Valente, Astrid Botty Van den Bruele, Luis O. Vasconez, Doctor Honoris Causa, Frank A. Vicini, Rebecca K. Viscusi, Daniel W. Visscher, Victor G. Vogel, Adrienne G. Waks, Irene L. Wapnir, Thomas Wells, Julia White, Max S. Wicha, Eric P. Winer, Kari B. Wisinski, Debra A. Wong, Teresa K. Woodruff, Eric J. Wright, Melissa Young, Zachary T. Young
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::89688fade8c889a3ec75763fef63b4ae
https://doi.org/10.1016/b978-0-323-35955-9.00090-8
https://doi.org/10.1016/b978-0-323-35955-9.00090-8
Autor:
Devi Gunasekera, Maochang Liu, Janice S. Withycombe, Eddie A. James, Richard J. Hughes, John C. Barrett, Shelley N Fletcher, Kathleen P. Pratt, Ruth A. Ettinger, Melinda S. Epstein, Dana C. Matthews
Publikováno v:
Blood. 126:895-904
African American hemophilia A (HA) patients experience a higher incidence of neutralizing antibodies (“inhibitors”) against factor VIII (FVIII) vis-à-vis Caucasian patients. Non-HA-causing non-synonymous single-nucleotide polymorphisms (ns-SNPs)
Autor:
Ruth A. Ettinger, Richard J. Hughes, Tom E. Howard, Christopher E. Walsh, Raymond G. Watts, Neil C. Josephson, Kenneth B. Lewis, Craig M. Kessler, Melinda S. Epstein, Kathleen P. Pratt, Rebecca Kruse-Jarres, Nigel S. Key, Christine L. Kempton, Jeanne M. Lusher
Publikováno v:
PLoS ONE, Vol 8, Iss 5, p e61120 (2013)
PLoS ONE
PLoS ONE
Evidence of antibody isotype/subtype switching may provide prognostic value regarding the state of immune responses to therapeutic proteins, e.g. anti-factor VIII (FVIII) antibodies that develop in many hemophilia A patients, clinically termed “inh